共 50 条
- [2] Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19 [J]. Clinical Drug Investigation, 2020, 40 : 893 - 895
- [6] Repurposed Tocilizumab in Patients with Severe COVID-19 [J]. JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
- [9] Impact of tocilizumab administration on mortality in severe COVID-19 [J]. Scientific Reports, 10
- [10] Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1503 - 1516